Free Trial
NASDAQ:ALVO

Alvotech (ALVO) Stock Price, News & Analysis

Alvotech logo
$8.52 -0.21 (-2.41%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$8.60 +0.08 (+0.94%)
As of 07/11/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alvotech Stock (NASDAQ:ALVO)

Key Stats

Today's Range
$8.50
$8.80
50-Day Range
$7.96
$11.58
52-Week Range
$7.35
$13.70
Volume
170,159 shs
Average Volume
146,754 shs
Market Capitalization
$2.57 billion
P/E Ratio
23.03
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Alvotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

ALVO MarketRank™: 

Alvotech scored higher than 54% of companies evaluated by MarketBeat, and ranked 479th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alvotech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Alvotech has received no research coverage in the past 90 days.

  • Read more about Alvotech's stock forecast and price target.
  • Earnings Growth

    Earnings for Alvotech are expected to grow in the coming year, from ($0.07) to $0.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alvotech is 23.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alvotech is 23.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.96.

  • Read more about Alvotech's valuation and earnings.
  • Percentage of Shares Shorted

    1.63% of the float of Alvotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Alvotech has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Alvotech has recently increased by 28.06%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Alvotech does not currently pay a dividend.

  • Dividend Growth

    Alvotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.63% of the float of Alvotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Alvotech has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Alvotech has recently increased by 28.06%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Alvotech has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Alvotech this week, compared to 5 articles on an average week.
  • Search Interest

    6 people have searched for ALVO on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
Receive ALVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alvotech and its competitors with MarketBeat's FREE daily newsletter.

ALVO Stock News Headlines

Alvotech: A Fast-Expanding Biosimilar Concern
Alvotech Appoints New CFO Amidst Continued Growth
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
Alvotech acquires Ivers-Lee Group
See More Headlines

ALVO Stock Analysis - Frequently Asked Questions

Alvotech's stock was trading at $13.23 on January 1st, 2025. Since then, ALVO shares have decreased by 35.6% and is now trading at $8.52.

Alvotech (NASDAQ:ALVO) issued its quarterly earnings data on Wednesday, May, 7th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.52. Alvotech had a net margin of 16.42% and a negative trailing twelve-month return on equity of 36.37%.
Read the conference call transcript
.

Shares of ALVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alvotech investors own include Micron Technology (MU), Arista Networks (ANET), United Microelectronics (UMC), Weatherford International (WFRD), NVIDIA (NVDA), PACCAR (PCAR) and Axcelis Technologies (ACLS).

Company Calendar

Last Earnings
5/07/2025
Today
7/11/2025
Next Earnings (Estimated)
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALVO
Previous Symbol
NYSE:ALVO
CIK
1898416
Fax
N/A
Employees
1,032
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$18.00
Potential Upside/Downside
+111.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.37
Trailing P/E Ratio
23.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$231.86 million
Net Margins
16.42%
Pretax Margin
-44.43%
Return on Equity
-36.37%
Return on Assets
12.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.73
Quick Ratio
1.19

Sales & Book Value

Annual Sales
$585.60 million
Price / Sales
4.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.37) per share
Price / Book
-6.22

Miscellaneous

Outstanding Shares
301,482,000
Free Float
300,095,000
Market Cap
$2.57 billion
Optionable
Not Optionable
Beta
0.11
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ALVO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners